Search Results - "Bádenas, C"

Refine Results
  1. 1
  2. 2
  3. 3
  4. 4

    Should cell‐free DNA testing be used in pregnancy with increased fetal nuchal translucency? by Miranda, J., Paz y Miño, F., Borobio, V., Badenas, C., Rodriguez‐Revenga, L., Pauta, M., Borrell, A.

    Published in Ultrasound in obstetrics & gynecology (01-05-2020)
    “…ABSTRACT Objective To assess the frequency of atypical chromosomal and submicroscopic anomalies, as well as fetal structural abnormalities, observed on…”
    Get full text
    Journal Article
  5. 5

    POT1 germline mutations but not TERT promoter mutations are implicated in melanoma susceptibility in a large cohort of Spanish melanoma families by Potrony, M., Puig‐Butille, J.A., Ribera‐Sola, M., Iyer, V., Robles‐Espinoza, C.D., Aguilera, P., Carrera, C., Malvehy, J., Badenas, C., Landi, M.T., Adams, D.J., Puig, S.

    Published in British journal of dermatology (1951) (01-07-2019)
    “…Summary Background Germline mutations in telomere‐related genes such as POT1 and TERT predispose individuals to familial melanoma. Objectives To evaluate the…”
    Get full text
    Journal Article
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10

    Dermoscopy comparative approach for early diagnosis in familial melanoma: influence of MC1R genotype by Longo, C., Barquet, V., Hernandez, E., Marghoob, A.A., Potrony, M., Carrera, C., Aguilera, P., Badenas, C., Malvehy, J., Puig, S.

    “…Background MC1R polymorphisms interact with CDKN2A mutations modulating melanoma risk and contribute to a less suspicious clinical and dermoscopic appearance…”
    Get full text
    Journal Article
  11. 11
  12. 12

    Late‐onset cutaneous porphyria in a patient heterozygous for a uroporphyrinogen III synthase gene mutation by Aguilera, P., Badenas, C., Whatley, S.D., To‐Figueras, J.

    Published in British journal of dermatology (1951) (01-12-2016)
    “…Summary Deficiency of uroporphyrinogen III synthase (UROS) causes congenital erythropoietic porphyria (CEP). The disease, originating from the inheritance of…”
    Get full text
    Journal Article
  13. 13

    Acquired erythropoietic uroporphyria secondary to myelodysplastic syndrome with chromosome 3 alterations: a case report by Podlipnik, S., Guijarro, F., Combalia, A., To‐Figueras, J., Badenas, C., Costa, D., Rozman, M., Jorge, S., Aguilera, P., Gaya, A.

    Published in British journal of dermatology (1951) (01-08-2018)
    “…Summary Congenital erythropoietic porphyria is a rare autosomal recessive disease caused by a deficiency of uroporphyrinogen III synthase, owing to mutations…”
    Get full text
    Journal Article
  14. 14

    Mutational status of naevus-associated melanomas by Shitara, D., Tell-Martí, G., Badenas, C., Enokihara, M.M.S.S., Alós, L., Larque, A.B., Michalany, N., Puig-Butille, J.A., Carrera, C., Malvehy, J., Puig, S., Bagatin, E.

    Published in British journal of dermatology (1951) (01-09-2015)
    “…Summary Background The origin of melanoma has always been a debated subject, as well as the role of adjacent melanocytic naevi. Epidemiological and…”
    Get full text
    Journal Article
  15. 15

    Benefits of oral Polypodium Leucotomos extract in MM high-risk patients by Aguilera, P., Carrera, C., Puig-Butille, J.A., Badenas, C., Lecha, M., González, S., Malvehy, J., Puig, S.

    “…Background  UV radiation and the presence of melanocytic nevi are the main risk factors of sporadic melanoma (MM). Protection of skin by an oral…”
    Get full text
    Journal Article
  16. 16

    POT1 and TERT promoter molecular screening in Spanish melanoma families by Potrony, M., Puig‐Butille, J.A., Ribera‐Sola, M., Iyer, V., Robles‐Espinoza, C.D., Aguilera, P., Carrera, C., Malvehy, J., Badenas, C., Landi, M.T., Adams, D.J., Puig, S.

    Published in British journal of dermatology (1951) (01-07-2019)
    “…Summary Melanoma is an aggressive type of skin cancer. Each year more than 250,000 new cases are diagnosed worldwide. If diagnosed at early stages, melanoma…”
    Get full text
    Journal Article
  17. 17
  18. 18
  19. 19
  20. 20

    Genetic susceptibility to cutaneous melanoma in southern Switzerland: role of CDKN2A, MC1R and MITF by Mangas, C., Potrony, M., Mainetti, C., Bianchi, E., Carrozza Merlani, P., Mancarella Eberhardt, A., Maspoli-Postizzi, E., Marazza, G., Marcollo-Pini, A., Pelloni, F., Sessa, C., Simona, B., Puig-Butillé, J.A., Badenas, C., Puig, S.

    Published in British journal of dermatology (1951) (01-11-2016)
    “…Summary Background Nearly 10% of all cases of cutaneous melanoma (CM) occur in patients with a personal or family history of the disease. Objectives To obtain…”
    Get full text
    Journal Article